The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface fas (CD95) and resistance to Fas-induced apoptosis

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8299-8306

  Shisler, Joanna ^a,c   Yang, Chi ^a   Walter, Barbara ^b   Ware, Carl F ^b   Gooding, Linda R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOMODULATION; PRIORITY JOURNAL;

EID: 0030874023     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8299-8306.1997     Document Type: Article

References (62)

1. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
2. Beidler, D. R., M. Tewari, P. D. Friesen, G. Poirier, and V. M. Dixit. 1995. The baculovirus p35 protein inhibits Fas-and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270:16526-16528.
3. Boss, J. M., S. M. Laster, and L. R. Gooding. 1991. Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts. Immunology 73:309-315.
4. Brady, H. A., A. Scaria, and W. S. Wold. 1992. Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J. Virol. 66:5914-5923.
5. Brady, H. A., and W. S. Wold. 1987. Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus. Nucleic Acids Res. 15:9397-416.
6. Browning, J. L., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867-878.
7. Carlin, C. R., A. E. Tollefson, H. A. Brady, B. L. Hoffman, and W. S. Wold. 1989. Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus. Cell 57:135-144.
8. Chinnaiyan, A. M., C. G. Tepper, M. F. Seldin, K. O'Rourke, F. Kischekel, S. Hellbardt, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FADD/ MORT1 is a common mediator of CD95 (Fas/APO-1)-and TNF-receptor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
9. Chiou, S.-K., L. Rao, and E. White. 1994. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14:2556-2563.
10. Chiou, S.-K., C.-C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-6566.
11. Cleveland, J. L., and J. N. Ihle. 1995. Contenders in FasL/TNF death signaling. Cell 81:479-182.
12. Compston, D. A. S., B. N. Vakarelis, E. Paul, W. I. McDonald, J. R. Batchelor, and C. A. Mims. 1986. Viral infection in patients with multiple sclerosis and HLA-DR matched control. Brain 109:325-344.
13. Datta, R., H. Kojima, D. Banach, N. J. Bump, R. V. Talanian, E. S. Alnemri, R. R. Weichselbaum, W. W. Wong, and D. W. Kufe. 1997. Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J. Biol. Chem. 272:1965-1969.
14. Dhein, J., P. T. Daniel, B. C. Trauth, A. Oehm, and P. Moller. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166-3173.
15. Duerksen-Hughes, P., W. S. M. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:4193-4200.
16. Fox, J. P., C. D. Brandt, F. E. Wassermann, C. E. Hall, I. Spigland, A. Kogon, and L. R. Elveback. 1969. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. Am. J. Epidemiol. 89:25-50.
17. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
18. Gooding, L. R., L. Aquino, P. J. Duerksen-Hughes, D. Day, T. M. Horton, S. Yei, and W. S. M. Wold. 1991. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells hut not of mouse cells. J. Virol. 65:3083-3094.
19. Gooding, L. R., L. W. Elmore, A. E. Tollefson, H. A. Brady, and W. S. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis hy tumor necrosis factor. Cell 53:341-346.
20. Gooding, L. R., T. S. Ranheim, A. E. Tollefson, L. Aquino, P. Duerksen-Hughes, T. M. Horton, and W. S. M. Wold. 1991. The 10.400-and 14.500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65:4114-4123.
21. Goodwin, R., D. Anderson, R. Jerzy, T. Davis, C. Brannan, N. Copeland, N. Jenkins, and C. Smith. 1991. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol. Cell. Biol. 11:3020-3026.
22. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192.
23. Hashimoto, S., A. Ishii, and S. Yonehara. 1991. The E1B oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3:343-351.
24. Hoffman, P., and C. Carlin. 1994. Adenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradation. Mol. Cell. Biol. 14:3695-3706.
25. Hoffman, P., P. Rajakumar, B. Hoffman, R. Heuertz, W. S. Wold, and C. R. Carlin. 1992. Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism. J. Virol. 66:197-203.
26. Horowitz, M. S. 1996. Adenoviruses, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
27. Horton, T. M., T. S. Ranheim, L. Aquino, D. I. Kusher, S. K. Saha, C. F. Ware, W. S. Wold, and L. R. Gooding. 1991. Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J. Virol. 65:2629-2639.
28. Horvath, J., L. Palkonyay, and J. Weber. 1986. Group C adenovirus DNA sequences in human lymphoid cells. J. Virol. 59:189-192.
29. Jones, N., and T. Shenk. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683-689.
30. Ju, S. T., H. Cui, D. J. Panka, R. Ettinger, and R. A. Marshak. 1994. Participation of target Fas protein in apoptosis pathway induced by CD44-Th1 and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185-4189.
31. Klas, C., K.-M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625-630.
32. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
33. Kolesnick, R. N., A. Haimovitz-Friedman, and Z. Fuks. 1994. The sphingo-myelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. Cell Biol. 72:471-474.
34. Krajcsi, P., A. E. Tollefson, C. W. Anderson, A. R. Stewart, C. R. Carlin, and W. S. Wold. 1992. The E3-10.4K protein of adenovirus is an integral membrane protein that is partially cleaved between Ala22 and Ala23 and has a Ccyt orientation. Virology 187:131-144.
35. Krajcsi, P., A. E. Tollefson, C. W. Anderson, and W. S. Wold. 1992. The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J. Virol. 66:1665-1673.
36. Krajcsi, P., A. E. Tollefson, and W. S. Wold. 1992. The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylated. Virology 188:570-579.
37. Krajcsi, P., and W. S. Wold. 1992. The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. Virology 187:492-498.
38. Kuivinen, E., B. L. Hoffman, P. A. Hoffman, and C. R. Carlin. 1993. Structurally related class I and II receptor protein tyrosine kinases are down-regulated by the same E3 proteins coded for by human group C adenoviruses. J. Cell Biol. 120:1271-1279.
39. Leithauser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K. Debatin, P. Krammer, and P. Moller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Investi. 69:415-429.
40. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. W. Wong, E. Y. Chen, and D. V. Goeddel. 1991 Cloning and expressing of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci USA 88:2830-2834.
41. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355-365.
42. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science 267:1449-1456.
43. Rao, L., and E. White. 1997. Bcl-2 and the ICE family of apoptotic regulators' making a connection. Curr. Opin. Genet. Dev. 7:52-58.
44. Rawle, F. C., A. E. Tollefson, W. S. Wold, and L. R. Gooding. 1989. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J. Immunol. 143:2031-2037.
45. Reddy, V. B., S. S. Tevethia, M. J. Tevethia, and S. M. Weismann. 1982. Nonselective expression of simian virus 40 large tumor antigen fragments in mouse cells. Proc. Natl. Acad. Sci. USA 79:4064-4067.
46. Stephens, C., and E. Harlow. 1987. Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins. EMBO J. 6:2027-2035.
47. Stewart, A. R., A. E. Tollefson, P. Krajcsi, S. P. Yei, and W. S. M. Wold. 1995. The adenovirus E3-10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. J. Virol. 69:172-181.
48. Suda, T., T. Takahashi, P. Goldstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis family. Cell 75:1169-1178.
49. Tartaglia, L. A., T. M. Ayers, G. H. W. Wong, and D. V. Goedell. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853.
50. Tewari, M., and V. M. Dixit. 1995. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:3255-3260.
51. Tollefson, A. E., P. Krajcsi, S. P. Yei, C. R. Carlin, and W. S. Wold. 1990. A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus. J. Virol. 64:794-801.
52. Tollefson, A. E., A. R. Stewart, S. P. Yei, S. K. Saha, and W. S. Wold. 1991. The 10,400-and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J. Virol. 65:3095-3105.
53. Trauth, B., C. Klas, A. Peters, S. Matzku, P. F. Moller, K. Debatin, and P. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305.
54. Vignaux, F., E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Goldstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181: 781-786.
55. Wantanabe-Funkunaga, R., C. I. Brannan, N. G. Copeland, N. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 356:314-317.
56. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
57. White, E., and R. Cipriani. 1989. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene Proc. Natl. Acad. Sci. USA 86:9886-9890.
58. White, E., P. Sabbatini, M. Debbas, W. S. M. Wold, D. I. Kusher, and L. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12:2570-2580.
59. Wold, W. S., S. L. Deutscher, N. Takemori, B. M. Bhat, and S. C. Magie. 1986. Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA region E3 of adenovirus. Virology 148:168-80.
60. Wong, G. H. W., and D. V. Goeddel. 1994. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152:1751-1755.
61. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
62. Yonehara, S., A. Ishiik, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.